STALLION Stallion India Fluorochemicals Q1 FY27 results (Apr–Jun 2026) and concall
Stallion India Fluorochemicals reported strong Q1 FY27 results with significant YoY growth in revenue, EBITDA, and PAT, driven by a favorable product mix and inventory gains. The company is progressing with its Khalapur helium plant, Mambattu facility, and R32 manufacturing plant, though the latter two have seen some delays. Management maintained its long-term growth guidance and indicated a potential shift in capital allocation strategy to include equity dilution for faster expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 10.0%, net profit up 90.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 68 | 85 | 152 | 110 | 106 +56% | 105 +24% | 110 −28% | 121 +10% |
| EBITDA | 2 | 14 | 19 | 14 | 16 +700% | 12 −14% | 16 −16% | 22 +57% |
| Net profit | 1 | 10 | 13 | 10 | 11 +1000% | 11 +10% | 11 −15% | 19 +90% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
